EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

The risk of developing splanchnic vein thrombosis in acute pancreatitis increases 3 days after symptom onset: A systematic review and meta‐analysis

Ruben Zsolt Borbély iD, Eszter Ágnes Szalai iD, Bryan Mangalath Philip iD, Dalma Dobszai iD, Brigitta Teutsch iD, Ádám Zolcsák iD, Dániel Sándor Veres iD, Bálint Erőss iD, Bálint Gellért iD, Péter Jenő Hegyi iD, Péter Hegyi iD, Nándor Faluhelyi iD

United European Gastroenterology Journal · 2024

DOI: 10.1002/ueg2.12550 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Ruben Zsolt Borbély und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Venous Thrombosis, Pancreatitis, Splanchnic Circulation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Translational Neuroscience National Laboratory Program, Translational Medicine Foundation, Hungarian Ministry of Innovation and Technology, National Research, Development and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Splanchnic vein thrombosis is a complication of acute pancreatitis (AP) and is likely often underdiagnosed.

Objectives

We aimed to understand the time course and risk factors of splanchnic vein thrombosis in the early phase of AP.

Methods

A systematic search was conducted using the PRISMA guidelines (PROSPERO registration CRD42022367578). Inclusion criteria were appropriate imaging techniques in adult AP patients, studies that reported splanchnic vein thrombosis data from the early phase, and reliable information on the timing of imaging in relation to the onset of pancreatitis symptoms or hospital admission. The proportion of patients with thrombosis with 95% confidence intervals (CI) was calculated using random‐effects meta‐analyses, and multiple subgroup analyses were performed.

Results

Data from 1951 patients from 14 studies were analyzed. The proportion of patients with splanchnic vein thrombosis within 12 days after symptom onset was 0.13 (CI 0.07–0.23). The occurrence was lowest at 0.06 (CI 0.03–0.1) between 0 and 3 days after symptom onset, and increased fourfold to 0.23 (CI 0.16–0.31) between 3 and 11 days. On hospital admission, the proportion of patients affected was 0.12 (CI 0.02–0.49); it was 0.17 (CI 0.03–0.58) 1–5 days after admission. The prevalence in mild, moderate, and severe AP was 0.15 (CI 0.05–0.36), 0.26 (CI 0.15–0.43), and 0.27 (CI 0.17–0.4), respectively. Alcoholic etiology (0.31, CI 0.13–0.58) and pancreatic necrosis (0.55, CI 0.29–0.78, necrosis above 30%) correlated with increased SVT prevalence.

Conclusion

The risk of developing splanchnic vein thrombosis is significant in the early stages of AP and may affect up to a quarter of patients. Alcoholic etiology, pancreatic necrosis, and severity may increase the prevalence of splanchnic vein thrombosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThrombosisPancreatitisSplanchnic CirculationHumansRisk FactorsTime Factors

Stichwörter der Autor:innen

portal vein thrombosisportosplenomesenteric venous thrombosissplenic vein thrombosissuperior mesenteric vein thrombosis

Autor:innen und Institutionen

  • Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Department of Medical Imaging, Bajcsy-Zsilinszky Hospital and Clinic, Budapest, Hungary.
  • Department of Restorative Dentistry and Endodontics, Semmelweis University, Budapest, Hungary.
  • Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
  • Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary.
  • Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary.

ORCID-Profile: Ruben Zsolt Borbély, Eszter Ágnes Szalai, Bryan Mangalath Philip, Dalma Dobszai, Brigitta Teutsch, Ádám Zolcsák, Dániel Sándor Veres, Bálint Erőss, Bálint Gellért, Péter Jenő Hegyi, Péter Hegyi, Nándor Faluhelyi

Förderung

  • Translational Neuroscience National Laboratory Program
  • Translational Medicine Foundation
  • Hungarian Ministry of Innovation and Technology, National Research, Development and Innovation Fund
  • ÚNKP-22-3 New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fu…

Zitieren

APA

Borbély, R. Z., Szalai, E. Á., Philip, B. M., Dobszai, D., Teutsch, B., Zolcsák, Á., Veres, D. S., Erőss, B., Gellért, B., Hegyi, P. J., Hegyi, P., & Faluhelyi, N. (2024). The risk of developing splanchnic vein thrombosis in acute pancreatitis increases 3 days after symptom onset: A systematic review and meta‐analysis. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12550

Vancouver

Borbély RZ, Szalai EÁ, Philip BM, Dobszai D, Teutsch B, Zolcsák Á, et al. The risk of developing splanchnic vein thrombosis in acute pancreatitis increases 3 days after symptom onset: A systematic review and meta‐analysis. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12550

BibTeX
@article{Borbly2024,
  author = {Borbély, Ruben Zsolt and Szalai, Eszter Ágnes and Philip, Bryan Mangalath and Dobszai, Dalma and Teutsch, Brigitta and Zolcsák, Ádám and Veres, Dániel Sándor and Erőss, Bálint and Gellért, Bálint and Hegyi, Péter Jenő and Hegyi, Péter and Faluhelyi, Nándor},
  title = {The risk of developing splanchnic vein thrombosis in acute pancreatitis increases 3 days after symptom onset: A systematic review and meta‐analysis},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  doi = {10.1002/ueg2.12550}
}
Kostenlos starten →